Spruce Biosciences Inc (SPRB)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -412.901 | -276.497 | -35.255 | -29.23 | -43.539 | -50.549 |
Return on Equity (%) | 110.752 | 54.039 | -49.733 | -32.433 | -51.352 | -66.097 |
Return on Invested Capital (%) | -964.41 | -1093.617 | -38.965 | -35.986 | -61.297 | -69.891 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -470.175 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -474.963 |
Book Value Per Share | 2.709 | -3.696 | 6.424 | 4.741 | 2.902 | 1.879 |
Earnings Per Share | -12.903 | -17.131 | -1.27 | -1.8 | -1.957 | -1.177 |
Cash Per Share | 5.382 | 5.136 | 6.756 | 1.82 | 1.038 | 2.366 |
Working Capital Per Share | 2.707 | 0.457 | 6.476 | 3.534 | 3.015 | 1.909 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | 0.248 |
EBIT Per Share | -12.903 | -17.131 | -1.27 | -1.8 | -1.957 | -1.177 |
EBITDA Per Share | -12.903 | -17.131 | -1.27 | -1.8 | -1.957 | -1.177 |
Free Cash Flow Per Share | -12.904 | -17.141 | -1.268 | -1.799 | -1.959 | -1.179 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 764k | 764k | 23,26M | 23,49M | 23,6M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 23,6M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -644.603 | N/A | N/A | N/A | -575.824 | N/A | N/A |
Net Profit Margin (%) | N/A | -651.273 | N/A | N/A | N/A | -580.669 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 18,07M |
Ratio cours/bénéfice | -0,37 |
Ratio prix/ventes | 1,76 |
Ratio prix/liquidités | 0,18 |
Ratio prix/valeur comptable | 0,23 |
Rendement de dividende | - |
Actions en circulation | 41,3M |
Volume moyen (1 semaine) | 580,57k |
Volume moyen (1 mois) | 942,88k |
Variation sur 52 semaines | -85,57% |
Plus haut sur 52 semaines | 5,95 |
Plus bas sur 52 semaines | 0,365 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales